Skip to main content
. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2

Garcia Ruiz 2005.

Methods A cost‐effectiveness analysis in the setting of the Spanish National Health System
Participants Patients with COPD
Interventions Tiotropium versus ipratropium or salmeterol
Outcomes FEV1, quality of life (SGRQ), dyspnoea (TDI), mean stay in hospital, exacerbations and direct healthcare costs associated with hospital treatment
Notes